Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Details)

v3.19.3.a.u2
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Basic and diluted numerator:        
Net loss attributable to iBio, Inc. stockholders $ (3,762) $ (4,469) $ (8,225) $ (8,867)
Deemed dividends - down round of Series A Preferred and Series B Preferred (21,560) 0 (21,560) 0
Preferred stock dividends (65) (65) (131) (131)
Net loss available to iBio, Inc. stockholders $ (25,387) $ (4,534) $ (29,916) $ (8,998)
Basic and diluted denominator:        
Weighted-average common shares outstanding 36,917 18,688 29,420 18,291
Per share amount $ (0.69) $ (0.24) $ (1.02) $ (0.49)